Clinical Trials
33 trialsPan Tumor Rollover Study
Bristol-Myers Squibb
TAPUR
American Society of Clinical Oncology
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Eastern Cooperative Oncology Group
Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
Genfit
Pediatric Long-Term Follow-up and Rollover Study
Novartis
MegaMOST
Centre Leon Berard
Dabrafenib and/or Trametinib Rollover Study
Novartis
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
Therapeutic Advances in Childhood Leukemia Consortium
Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer
City of Hope Medical Center
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors
Vividion Therapeutics, Inc.
A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
Memorial Sloan Kettering Cancer Center
NeoLATC
Fujian Medical University
Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma
University of Kentucky
Special Drug Use-results Surveillance of Tafinlar/Mekinist
Novartis
HEM-iSMART D
Princess Maxima Center for Pediatric Oncology
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
Bristol-Myers Squibb
MELAFERT: Impact of Adjuvant Therapy on FERTility in Patients With Resected MELAnoma at High Risk of Relapse.
Intergruppo Melanoma Italiano
A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer
Fudan University
PLGG - MEKTRIC
University Hospital, Strasbourg, France
MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
Ann & Robert H Lurie Children's Hospital of Chicago
Imatinib and Trametinib for KRAS-mutated Solid Tumor
China Medical University Hospital
MATRIX-Rare
Oslo University Hospital
Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment Exhaustion
Tianjin Medical University Second Hospital
Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer
West China Hospital
NETCAM
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
EROS
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
ALTREM
Assistance Publique Hopitaux De Marseille
FINPROVE
Helsinki University Central Hospital
Study of the Rechallenge Concept in Patients With BRAF-positive Anaplastic Thyroid Cancer After Progression on Anti-BRAF Therapy
Saint Petersburg State University, Russia
Swecranio
Skane University Hospital
DRUP
The Netherlands Cancer Institute
NEO-ATACT
Leiden University Medical Center
MEMBRAINS
Herlev Hospital